http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf4128052c5bf623a4cd9968eb4be8e2
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Chen |
| name | Taiping Chen |
| given-name | Taiping |
| organization-name | Terry Fox Molecular Oncology Group, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, and Departments of Oncology, Medicine, and Microbiology and Immunology, McGill University, Montréal, Québec H3T 1E2, Canada Epigenetics Program, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139. Terry Fox Molecular Oncology Group, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, and Departments of Oncology, Medicine, and Microbiology and Immunology, McGill University, Montréal, PQ H3T 1E2, Canada Terry Fox Molecular Oncology Group, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, and Departments of Oncology, Medicine, and Microbiology and Immunology, McGill University, Montréal, Québec H3T 1E2, Canada; and Department of Epigenetics and Molecular CarcinogenesisThe University of Texas M. D. Anderson Cancer Center Smithville Texas USA Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA Epigenetics Program, Novartis Institute for Biomedical Research, Cambridge, Massachusetts School of Chemical Engineering, Sichuan University, Chengdu 610065, Sichuan, China Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, 1808 Park Road 1C, Smithville, TX, 78957, USA. tchen2@mdanderson.org. Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, 1808 Park Road 1C, Smithville, TX, 78957, USA. tchen2@mdanderson.org. Graduate School of Biomedical Sciences at Houston, Houston, TX, 77030, USA. tchen2@mdanderson.org. Cutaneous Biology Research Center and Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129 Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center , Houston , TX 77030 , USA; Program in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences , Houston , TX 77030 , USA Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA; Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA; Program in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA Department of Epigenetics and Molecular Carcinogenesis, Division of Basic Science Research, The University of Texas M. D. Anderson Cancer Center, Smithville, TX 78957; Epigenetics Program, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139 Terry Fox Molecular Oncology Group, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Departments of Oncology, Medicine and Microbiology and Immunology, McGill University, Montreal, Quebec H3T 1E2 Department of Epigenetics and Molecular Carcinogenesis, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Program in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. tchen2@mdanderson.org. Programs in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. tchen2@mdanderson.org. 1Wood Hudson Cancer Research Laboratory, Newport, Kentucky; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown; Epigenetics Program, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts Department of Epigenetics & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Science Park – Research Division, 1808 Park Road 1C, P. O. Box 389, Smithville, TX 78957, USA; Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Science Park, 1808 Park Road 1C, Smithville, TX 78957, USA; The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA. Authors' Affiliations: 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan; 2Biomolecular Characterization Team, RIKEN and CREST, Wako, Saitama, Japan; 3Laboratory for Biomarker Development, RIKEN, Minato-ku, Tokyo, Japan; 4Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; 5Department of Genetics, University of Cambridge, Cambridge, United Kingdom; and 6Department of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge, Cambridge, United Kingdom Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA. Crown Bioscience Inc., Light Muller Building, Changping Sector of Zhongguancun Science Park, No.21 Huoju Street, Changping District, Beijing 102200, P. R. China Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA.; Epigenetics Program, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA. Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139 Terry Fox Molecular Oncology Group, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, and Departments of Oncology, Medicine, and Microbiology and Immunology, McGill University, Montreal, Quebec H3T 1E2, Canada Department of Bioinformatics and Computational Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA. Department of Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Smithville, TX;; University of Texas Graduate School of Biomedical Sciences, Houston, TX |
Incoming Links
Total number of triples: 132.